Bridging the Evidence Gap: A Call to Action for Anticoagulation Research in Pediatric Burned Patients on Extracorporeal Membrane Oxygenation

Clicks: 13
ID: 333722
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #90 of 93 articles by views in journal of burn care & research : official publication of the american burn association

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
ABSTRACT Although early extracorporeal membrane oxygenation (ECMO) improves respiratory complications in unburned populations, it remains a rarely utilized rescue therapy in pediatric burn care, averaging just 3 to 6 cases annually worldwide despite a promising 53–62% survival rate. This underutilization stems from a profound therapeutic paradox: the high bleeding risks and need for coagulation inherent to burn wounds with necessary surgical debridement directly conflict with the systemic anticoagulation required to prevent ECMO circuit thrombosis. Importantly, emerging evidence demonstrates that systemic anticoagulation may not be an absolute requirement for veno-venous ECMO. Despite this, no guidance exists for anticoagulation management specifically in pediatric burned patients. A scoping review spanning three databases identified no studies describing a coagulation strategy developed or validated for this population. Addressing this evidence gap is essential to safely transition ECMO from a late rescue modality to an earlier, evidence-based intervention capable of reducing mortality in this patient population. We therefore call for (1) a multicenter collaboration to aggregate sufficient case volume for meaningful analysis; (2) a prospective collection of serial viscoelastic and conventional coagulation data in pediatric burned patients on ECMO to characterize the temporal evolution of coagulopathy on circuit; and (3) the development and validation of coagulation management protocols tailored to this population. Until such evidence exists, pediatric burned patients will continue to be denied a therapy that offers meaningful survival—not because ECMO does not work—but because we have not yet determined how best to manage coagulation while on circuit.
Reference Key
openalex_W7223312653 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal journal of burn care & research : official publication of the american burn association
Year 2026
DOI
10.1093/jbcr/irag175
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.